Patents by Inventor David Camerini

David Camerini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rapid immunoselection cloning method
    Patent number: 7119183
    Abstract: A simple and highly efficient method for cloning cDNAs including CD27 (SEQ ID NO:28) from mammalian expression libraries based on transient expression in mammalian host cells has been discovered. Novel expression vectors allowing highly efficient construction of mammalian cDNA libraries are disclosed. The cloning method of the invention which has been used to clone genes for cell surface antigens of human lymphocytes, has general application in gene cloning. Cell surface antigens cloned according to the present invention have been purified, and the nucleotide and amino acid sequences determined. These antigens have diagnostic and therapeutic utility in immune-mediated infections in mammals, including humans.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: October 10, 2006
    Assignee: The General Hospital Corporation
    Inventors: Brian Seed, Alejandro Aruffo, David Camerini
  • Rapid immunoselection cloning method
    Publication number: 20040072283
    Abstract: A simple and highly efficient method for cloning cDNAs from mammalian expression libraries based on transient expression in mammalian host cells has been discovered. Novel expression vectors allowing highly efficient construction of mammalian cDNA libraries are disclosed. The cloning method of the invention which has been used to clone genes for cell surface antigens of human lymphocytes, has general application in gene cloning. Cell surface antigens cloned according to the present invention have been purified, and the nucleotide and amino acid sequences determined. These antigens have diagnostic and therapeutic utility in immune-mediated infections in mammals, including humans.
    Type: Application
    Filed: April 17, 2001
    Publication date: April 15, 2004
    Inventors: Brian Seed, Janet Allen, Alejandro Aruffo, David Camerini, Leander Lauffer, Carmen Oquendo, David Simmons, Ivan Stamenkovic, Siegfried Stengelin, Martine Amiot
  • CD40 coding sequences
    Patent number: 5849898
    Abstract: A simple and highly efficient method for cloning cDNAs from mammalian expression libraries based on transient expression in mammalian host cells has been discovered. The present invention specifically provides the CD40 cDNA sequence.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 15, 1998
    Assignee: The General Hospital Corporation
    Inventors: Brian Seed, Janet Allen, Alejandro Aruffo, David Camerini, Leander Lauffer, Carmen Oquendo, David Simmons, Ivan Stamenkovic, Siegfried Stengelin, Martine Amiot
  • Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof
    Patent number: 5420264
    Abstract: The present invention relates, in general, to substantially pure polynucleotide molecules specifying chimpanzee or rhesus monkey CD4, and fragments thereof and Gp120 binding molecules related to human CD4. The present invention further relates to polynucleotide molecules specifying CD4 fusion proteins and host cells containing the polynucleotide molecules.
    Type: Grant
    Filed: July 17, 1992
    Date of Patent: May 30, 1995
    Assignee: The General Hospital Corporation
    Inventors: Brian Seed, David Camerini